Immunovia joins ”Light it purple” initiative on World Pancreatic Cancer Day
November 21, 2019 marks World Pancreatic Cancer Day (WPCD), when all of us around the world should raise awareness of the signs and symptoms of pancreatic cancer, which currently has the lowest survival rate of any cancer. The symptoms of pancreatic cancer can be vague and non-specific. As a result, pancreatic cancer is typically not diagnosed until it is too late, resulting in poor outcomes, with just 5-8% of patients surviving 5 years after diagnosis.
Since the creation of World Pancreatic Cancer Coalition (WPCC) and World Pancreatic Cancer Day, Immunovia has been joining all the efforts to raise awareness of pancreatic cancer around the globe. Also this year Immunovia honors World Pancreatic Cancer Day and sponsors different activities in collaboration with regional patient associations in Sweden, USA/Canada, UK, Spain and Germany.
Looking back at WPCD 2016-2019
We have brought together the voices of patient associations, patients and Key Opinion Leaders into a movie covering the three latest contributions of Immunovia’s pancreatic cancer awareness initiatives. The movie will be released on World Pancreatic Cancer Day on our dedicated website: www.worldpancreaticcancerday.se and on www.immunovia.com.
Immunovia WPCD 2019
Stockholm: An educational symposium at Karolinska Institutet in Stockholm organized by PALEMA, the Swedish patient association, highlights the progress made in detection and treatment of pancreatic cancer. Immunovia will be presenting the latest updates on IMMray™ PanCan-d in the session “New possibilities to detect cancer earlier”.
Immunovia will be streaming the program live. If you would like to watch this event, please visit worldpancreaticcancerday.se and tune in on November 21 at 3:00 PM (CET). The presentations will be in Swedish only.
Lund: In collaboration with Medicon Village to raise awareness of pancreatic cancer among all the members and companies at our site in Lund, the restaurant and the entrance to the new building “The Spark” will be lit in purple on World Pancreatic Cancer Day.
This year, Immunovia joined the global “Light it Purple” initiative, where landmarks throughout the world are lit purple to honor World Pancreatic Cancer Day and raise awareness of the signs and symptoms of pancreatic cancer. To date, over 88 landmarks in 44 states and 4 provinces throughout the United States and Canada have agreed to participate. For complete list of all purple landmarks, please visit: https://www.worldpancreaticcancerday.se/
The 2019 Annual Meeting of the Pancreatic Society of Great Britain and Ireland takes place in Liverpool, UK on November 21-22, 2019. Immunovia will be presenting “Recent data on identifying PDAC using the IMMray™ Platform” in the Early Detection and Diagnosis section and present a poster in the poster session.
Immunovia participated in the 5km run for pancreatic cancer organized by ACANPAN, the Spanish patient association with pancreatic cancer, on November the 10th 2019 (Carrera de las ciudades contra el cáncer de páncreas – http://carreracancerpancreas.es). So far, in the various editions, 25,655 people have participated in 6 different cities, running for 146,214 km and raising 355,000 EUR for research in pancreatic cancer.
In collaboration with World Pancreatic Cancer Coalition Immunovia has created a dedicated website in Spanish to raise awareness of the signs and symptoms of pancreatic cancer.
During the 6. Welt-Pankreaskrebstag (World Pancreatic Cancer Day) in Ludwigsburg, Germany, organized by TEB e.V. Selbsthilfe (one of the German patient associations), Immunovia will participate in the podium discussion “New ways, Chances, Hope” and raise the importance of early detection in pancreatic cancer, together with other representatives from research, pharma industry, physicians, health insurance, politicians and patient organizations.
Please join us at Immunovia in the effort to raise awareness of pancreatic cancer around the globe on World Pancreatic Cancer Day, November 21 2019 and wear purple.